Literature DB >> 11792315

Muscular dystrophy--reason for optimism?

Edward A Burton1, Kay E Davies.   

Abstract

Characterization of the mechanisms underlying various types of muscular dystrophy has been an outstanding triumph of molecular biology. Increasing clarification of the aberrant cellular processes responsible for these conditions may ultimately permit the development of effective means for molecular intervention, allowing correction of the abnormal cellular physiology that results in the dystrophic phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792315     DOI: 10.1016/s0092-8674(01)00626-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  16 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 2.  The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

Review 3.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

4.  ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.

Authors:  Pauliina Kronqvist; Nobuko Kawaguchi; Reidar Albrechtsen; Xiufeng Xu; Henrik Daa Schrøder; Behzad Moghadaszadeh; Finn Cilius Nielsen; Camilla Fröhlich; Eva Engvall; Ulla M Wewer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 5.  Mammalian O-mannosylation: unsolved questions of structure/function.

Authors:  Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Curr Opin Struct Biol       Date:  2011-09-22       Impact factor: 6.809

6.  Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies.

Authors:  Luciano Merlini; Alessia Angelin; Tania Tiepolo; Paola Braghetta; Patrizia Sabatelli; Alessandra Zamparelli; Alessandra Ferlini; Nadir M Maraldi; Paolo Bonaldo; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

Review 7.  Structure, function and pathology of O-mannosyl glycans.

Authors:  Tamao Endo
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Acetylcholinesterase mobility and stability at the neuromuscular junction of living mice.

Authors:  Isabel Martinez-Pena y Valenzuela; Mohammed Akaaboune
Journal:  Mol Biol Cell       Date:  2007-05-30       Impact factor: 4.138

Review 9.  O-Mannosylation and human disease.

Authors:  Christina M Dobson; Samuel J Hempel; Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Cell Mol Life Sci       Date:  2012-11-01       Impact factor: 9.261

10.  Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.

Authors:  Hiroshi Manya; Atsuro Chiba; Aruto Yoshida; Xiaohui Wang; Yasunori Chiba; Yoshifumi Jigami; Richard U Margolis; Tamao Endo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.